We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026

Molecular Probes Acquires Interfacial Dynamics

By HospiMedica staff writers
Posted on 30 Apr 2003
In a move to expand its bead-based assay systems, Molecular Probes, Inc. More...
(Eugene, OR, USA) has acquired Interfacial Dynamics Corp. (IDC, Portland, OR, USA). Financial terms were not disclosed.

IDC will become a wholly owned subsidiary of Molecular Probes. IDC was a pioneer in the production of surfactant-free, high-quality, reproducible latex microspheres. The acquisition gives Molecular Probes the ability to design and manufacture these latex microspheres for its own products and to offer a full line of microspheres to customers. Molecular Probes is a leading global provider of fluorescence-based detection assays.

"Adding IDC's outstanding capabilities in microsphere development and manufacturing to our expertise in fluorescence and conjugation, along with our relationships with major reagent, diagnostic, and instrument companies, gives us numerous opportunities to develop new bead-based assays and particle-based detection systems for a wide variety of uses,” said Anthony Martin, Ph.D., president and CEO of Molecular Probes.





Related Links:
Molecular Probes
Interfacial Dynamics

Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Immunofluorescence Analyzer
IFA System
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.